| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075499 For therapy of cancer |
| 04/07/2005 | US20050075498 Functionalized for wider applications; enhanced solvent solubility; simple reactions; ion sensors |
| 04/07/2005 | US20050075386 Drugs from indocasbazole derivatives |
| 04/07/2005 | US20050075383 Inhibitors of phophodiesterase type-IV |
| 04/07/2005 | US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075351 4-(Azaindol-3-yl)-quinazoline, 4-(azaoxindol-3-yl)-quinazoline, or 4-(diazaindol-3-yl)-quinazoline derivatives as glycogen synthase kinase inhibitors; Alzheimer's, Parkinson's, Huntington's disease; Down syndrome, amyotrophic lateral sclerosis; neurodegenerative and brain disorders; cognition activators |
| 04/07/2005 | US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 04/07/2005 | US20050075342 Pyrrolopyridazine derivatives |
| 04/07/2005 | US20050075340 Triazolotriazine compounds and uses thereof |
| 04/07/2005 | US20050075328 Such as (2'-methoxy-[1,1'-biphenyl]-4-yl)-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 04/07/2005 | US20050075273 condensation aerosols; for treatment of pain or alcohol abuse; kits |
| 04/07/2005 | US20050075272 Pyrimido compounds having antiproliferative activity |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | US20050073563 Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material |
| 04/07/2005 | CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | CA2539252A1 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/07/2005 | CA2537520A1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520450A1 Electroluminescent device |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519939A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 04/06/2005 | EP1519933A1 Quinuclidine amide derivatives |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519729A1 Pyrrolotriazinone compounds and their use to treat diseases |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1289996B1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604899A Hydroxycucurbituril derivatives, their preparation methods and uses |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604781A Use of desoxypeganine for treating clinical depression |
| 04/06/2005 | CN1603314A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/06/2005 | CN1195756C Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 04/06/2005 | CN1195755C Pyrrolo [2, 3-d] pyrimidine compounds |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/05/2005 | US6875877 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875784 Bactericides; grampositive, gramnegative bacteria |
| 04/05/2005 | US6875772 [1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists |
| 04/05/2005 | US6875770 Antiinflamamtory agents; side effect reduction |
| 04/05/2005 | US6875762 Tetracyclic azepinoindole compounds |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | CA2235138C Reverse-turn mimetics and methods relating thereto |
| 04/05/2005 | CA2145509C 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
| 03/31/2005 | WO2005028480A2 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | WO2005028477A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 03/31/2005 | WO2005028475A2 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | WO2005028434A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | WO2005007634A8 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 03/31/2005 | WO2005007622A3 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID DERIVATIVE WITH THE SAME |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | WO2005002520A3 Ophthalmic compositions for treating ocular hypertension |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004092172A3 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists |
| 03/31/2005 | WO2004092171A3 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists |
| 03/31/2005 | WO2004092170A3 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists |
| 03/31/2005 | WO2004064748A3 Compositions and methods for treatment of ovarian cancer |
| 03/31/2005 | US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/31/2005 | US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease |
| 03/31/2005 | US20050070591 Indole derivative |
| 03/31/2005 | US20050070588 Imidazolyl inhibitors of 15-lipoxygenase |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070566 Imidazoquinoline derivatives |
| 03/31/2005 | US20050070558 For example, [4-(2,4-Dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetic acid; useful in preventing mast cell degranulation and therefore useful in treatment of diseases induced by activation of A2b receptor and mast cell activation such as asthma, allergic reactions |
| 03/31/2005 | US20050070557 Use of pyrazolo(4,3-d)pyrimidine derivatives; for example, 5-(3-chloro-benzyl)-3-isopropyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one |
| 03/31/2005 | US20050070554 Substituted heterocyclic compounds and methods of use |
| 03/31/2005 | US20050070546 Tyrosine kinase inhibitors |
| 03/31/2005 | US20050070545 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism |
| 03/31/2005 | US20050070544 Such as 7-chloro-4-hydroxy-2-[3-(3-chlorophenyl)prop-2-ynyl]-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione; binds NMDA receptor glycine site |
| 03/31/2005 | US20050070542 1-(1-Ethyl-propyl)-5-(2-methoxy-4-trifluoromethoxy-phenyl)-3,6-dimethyl-1H-pyrazolo[3,4-b]pyrazine; modulators of corticotropin releasing factor receptors; for treatment of central nervous system and periphereal disorders (stress, anxiety, depression, cardiovascular disorders, and eating disorders) |
| 03/31/2005 | US20050070541 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 03/31/2005 | US20050070525 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one |
| 03/31/2005 | US20050070523 For therapy of bacterial infection in a mammal |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050069276 Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 03/31/2005 | CA2539548A1 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | CA2538789A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | CA2537731A1 Compositions useful as inhibitors of protein kinases |
| 03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
| 03/30/2005 | EP1518854A1 Substituted 06- benzylguanines and 7- or 9- substituted 8-aza-06-benzylguanines |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517904A2 Mitotic kinesin inhibitors |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517892A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 03/30/2005 | EP1517890A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 03/30/2005 | EP1253150B1 Polymeric micellar structure |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | CN1602312A Process for making carbapenem compounds |